Boy, is Joe going to be choked. Fungoff instead of FDA bundled with the news. <g>
BTW, Mrs Krupa mentioned that Joe cannot come to the computer right now, something to do with gaining 25lbs over night. <ggg>
NICE to see they got $2.5mm. Should alleviate the cash crunch. I calculated the shares went for $3.69. Plus.
A bit more than 2 years have gone by since DMX last mentioned onychomycosis in an NR. In my most simplistic mind, Fungoff clinicals should not take excessive time to complete, but you never know. I guess it depends on the end point. Either the formulation kills fungus or when fungi-toe nail grows out. Plus.
"...despite some regulatory delays in
PENNSAID approval," said Rebecca Keeler" Psst, this is a hint. Negative.
""We are very pleased to have extended our agreement with Acqua Wellington
for an additional few months, through May, 2002,"
Could be taken as a negative. Any other financing vehicles? When does revenues take off?
Overall, a neutral NR. May not help our stock price.
Let's see how the three amigos act on this news. That'll determine the short term direction.
Look, its almost christmas! Peace and goodwill to all men! |
